Metastx, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBellevue, PA
SAM.gov UEIEVGVK2KXJNM4
MetasTx develops a precision oncology platform for prostate cancer that combines a companion diagnostic test with a targeted cKit inhibitor therapy designed to identify and treat patients at high risk of cancer metastasis. The diagnostic is designed to detect a pattern in tumor cells that indicates likelihood of spread, while the therapeutic targets molecular signals that drive metastasis. The company serves the oncology and prostate cancer treatment industries.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Metastx, INC. | Bellevue | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.